You and your competitors are all competing for the attention of a shared customer base. So how can your brand and your experts stand out in such crowded industry conversation spaces? Earned media is an excellent way to accomplish this goal, but wanting coverage doesn’t mean that you’ll get it. To increase your company’s share of voice and secure awareness and thought leadership opportunities across the media landscape, you need a highly experienced, connected, and responsive public relations team and integrated strategy working on your behalf.
SCORR Marketing offers customizable PR support options that can be tailored to your specific awareness-building and reputation-establishing goals. Your next set of warm leads depends on your target audience knowing, liking, and trusting you — and that’s where the SCORR PR team comes in.
Utilizing our unique combination of life sciences PR knowledge and our extensive global network of industry publication and editor relationships, the award-winning SCORR PR team gains coverage and visibility for you while helping your subject matter experts establish credibility and build brand awareness. From articles to podcasts to awards to speaking opportunities to being quoted in just the right trade, regional, or local outlets, we will work with you to understand your goals and establish a custom PR strategy to meet them.
Experts too busy to write their own earned placements? We cover that for you, too. Our team of scientific writers is standing by to interview your experts and create the highest quality content from their expertise.
PR for Increased Brand Awareness
THE CLIENT
X-Chem is a drug discovery and development service provider specializing in small molecule DNA-encoded libraries (DELs). X-Chem’s founders and staff include pioneers of DEL technology and DEL-based drug discovery, including some of the most experienced experts in the world for hit identification and hit-to-lead optimization from DEL screens.
THE CHALLENGE
Despite having one of the inventors and pioneers of DEL technology and a well-renowned leader in AI for drug discovery on their executive team, X-Chem was struggling for awareness beyond their core customer base. They had grown their U.S.-based business, but exposure to and awareness of X-Chem’s brand was still relatively low across the world, with only a 1% share of voice (SOV) average compared to competitors.
THE SOLUTION
Beginning in February of 2022, SCORR worked with X-Chem for two years to build consistent coverage, setting goals to support increasing brand awareness through public relations strategies that included news releases, award submissions, and pitching to secure editorial and speaking opportunities.
THE OUTCOME
Over the course of two years, the SCORR PR team exponentially increased X-Chem’s earned media visibility and brand awareness:
- By June 2022 (five months into the campaign), we had surpassed all of X-Chem’s PR goals for the entire year
- By the end of December 2022 (11 months into the campaign), the SCORR PR team
- Increased X-Chem’s SOV from 1% to 38%
- Achieved 1,300+ media mentions in 11 months, nearly doubling mentions from 2021
- Secured earned media opportunities across 10+ publications — a more than 700% increase from the previous year
- Coordinated X-Chem winning submissions for three awards
- By February 2023 (first month of year two of the campaign), the SCORR PR team
- Achieved a number one SOV position for X-Chem among their competitors
- Doubled media mentions for X-Chem over 2022 and more than quadrupled them in two years’ time
- Created 1.5x more award opportunities for 2023
PR for Expanding Thought Leadership Reputation
Target audiences make decisions based on knowing, liking, and trusting you. Ensuring your subject matter experts’ reputation as thought leaders is essential to meeting this goal. Here’s how the SCORR PR team accomplished this for one of our clients.
THE CLIENT
At the end of 2022, Kindeva Drug Delivery merged with Meridian Medical Technologies. Overnight, the company became a top global contract development and manufacturing organization (CDMO). Kindeva develops and manufactures pulmonary & nasal, injectable, and transdermal combination products, and their service offerings span early-stage feasibility through commercial scale drug product fill-finish, container closure system manufacturing, and drug-device product assembly. They serve a global client base from state-of-the-art manufacturing, research, and development facilities located across the U.S. and U.K.
THE CHALLENGE
The newly combined company had very little published thought leadership spanning their broad, foundational array of drug-delivery expertise. They needed to quickly establish a reputation for their extensive history of innovation as well as their new scope of capabilities.
THE SOLUTION
From the end of 2022 through 2023, the SCORR PR team supported Kindeva’s business goal of being known as a global, innovative CDMO player through increased thought leadership.
THE OUTCOME
Since the announcement of the combined company, SCORR’s PR efforts supported a 15x increase in thought leadership by the end of 2023. More online visibility to Kindeva’s expertise was published across a variety of impactful industry publications, including:
- OINDP News
- Global Business Reports
- PharmTech
- American Pharmaceutical Review
- Drug Development & Delivery
- ONdrugDelivery
- Contract Pharma
- And more
Want More Leads? Increase Brand Awareness and Thought Leadership Reputation With SCORR Marketing.
The award-winning SCORR PR team is ready to customize an earned media strategy to align with your goals. The results above are examples of what we have accomplished. Are you ready to see what we can do for you?